Mark Watson
Direktor/Vorstandsmitglied bei ABRDN HEALTHCARE OPPORTUNITIES FUND
Profil
Mark Watson is currently the Director at H.
Lee Moffitt Cancer Center & Research Institute, Inc. since 2009.
He is also currently serving as an Independent Trustee at abrdn Healthcare Opportunities Fund starting in 2022.
Previously, Mr. Watson held positions as Director at Sykes Enterprises, Inc. from 2018 to 2021, Director at BioDelivery Sciences International, Inc. from 2017 to 2022, and Director at Inhibitor Therapeutics, Inc. from 2014 to 2022.
Aktive Positionen von Mark Watson
Unternehmen | Position | Beginn |
---|---|---|
ABRDN HEALTHCARE OPPORTUNITIES FUND | Direktor/Vorstandsmitglied | 09.06.2022 |
H. Lee Moffitt Cancer Center & Research Institute, Inc.
H. Lee Moffitt Cancer Center & Research Institute, Inc. Miscellaneous Commercial ServicesCommercial Services H. Lee Moffitt Cancer Center & Research Institute, Inc. provides research & contributions to clinical trials, prevention and cancer control. The firm operates as National Cancer Institute (NCI) Comprehensive Cancer Center. The company was founded by Lee H. Moffitt in 1981 and is headquartered in Tampa, FL. | Direktor/Vorstandsmitglied | 01.01.2009 |
Ehemalige bekannte Positionen von Mark Watson
Unternehmen | Position | Ende |
---|---|---|
INHIBITOR THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 13.12.2022 |
BIODELIVERY SCIENCES INTERNATIONAL, INC. | Direktor/Vorstandsmitglied | 02.01.2022 |
SYKES ENTERPRISES, INCORPORATED | Direktor/Vorstandsmitglied | 02.01.2021 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
INHIBITOR THERAPEUTICS, INC. | Health Technology |
Private Unternehmen | 4 |
---|---|
abrdn Healthcare Opportunities Fund
abrdn Healthcare Opportunities Fund Investment Trusts/Mutual FundsMiscellaneous Tekla Healthcare Opportunities Fund operates as a closed-end investment fund and investment trust. The trust's investment objective is to seek current income and long-term capital appreciation through investing in companies engaged in the healthcare industry, including equity securities, debt securities and pooled investment vehicles. The Trust was founded on April 2, 2014 and is headquartered in Boston, MA. | Miscellaneous |
BioDelivery Sciences International, Inc.
BioDelivery Sciences International, Inc. Pharmaceuticals: MajorHealth Technology BioDelivery Sciences International, Inc. operates as a pharmaceutical company engaged in the development and commercialization of new applications of approved therapeutics to address important unmet medical needs. Its products include Symproic and Belbuca. The company was founded on January 6, 1997 and is headquartered in Raleigh, NC. | Health Technology |
Sykes Enterprises, Inc.
Sykes Enterprises, Inc. Information Technology ServicesTechnology Services Sykes Enterprises, Inc. engaged in the provision of multichannel demand generation and global customer engagement services. It operates through the following segments: Americas, Europe, the Middle East and Africa (EMEA), and Other. The Americas segment includes the United States, Canada, Latin America, Australia, and the Asia Pacific Rim; and offers outsourced customer engagement solutions and technical staffing. The EMEA segment covers outsourced customer engagement solutions and fulfilment services. The Other segment represents other items such as corporate and other costs, other income and expense, and income taxes. The company was founded by John H. Sykes in 1977 and was headquartered in Miami, FL. | Technology Services |
H. Lee Moffitt Cancer Center & Research Institute, Inc.
H. Lee Moffitt Cancer Center & Research Institute, Inc. Miscellaneous Commercial ServicesCommercial Services H. Lee Moffitt Cancer Center & Research Institute, Inc. provides research & contributions to clinical trials, prevention and cancer control. The firm operates as National Cancer Institute (NCI) Comprehensive Cancer Center. The company was founded by Lee H. Moffitt in 1981 and is headquartered in Tampa, FL. | Commercial Services |